63468-02-0

Basic information

• Product Name: 5-methyloct-3-en-2-one
• Synonyms: 5-methyloct-3-en-2-one;5-Methyl-3-octen-2-one
• CAS NO: 63468-02-0
• Molecular Formula: C₉H₁₆O
• Molecular Weight: 140.22274
• EINECS: 264-248-3
• Mol File: 63468-02-0.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 195.7°C at 760 mmHg
• Flash Point: 77.1°C
• Appearance: /
• Density: 0.833g/cm³
• Vapor Pressure: 0.415mmHg at 25°C
• Refractive Index: 1.433
• CAS DataBase Reference: 5-methyloct-3-en-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-methyloct-3-en-2-one(63468-02-0)
• EPA Substance Registry System: 5-methyloct-3-en-2-one(63468-02-0)

Safety Data

• Hazardous Substances Data: 63468-02-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H16O/c1-4-5-8(2)6-7-9(3)10/h6-8H,4-5H2,1-3H3/b7-6+

Upstream product

• 123-15-9 2-methylvaleraldehyde 
• 67-64-1 acetone 
• 1439-36-7 1-triphenylphosphoranylidene-2-propanone 

Relevant articles and documents

BICYCLIC HETEROCYCLIC COMPOUND

In the prevention and/or treatment of a neuropsychiatric disease or a peripheral organ disease and the like, a pharmaceutical which comprises a compound having CRF antagonistic activity as an active ingredient is provided. A compound of a formula (I): wherein R1 represents a C3-10 branched alkyl group which may be substituted; R2 represents a hydrogen atom or a C1-4 alkyl group which may be substituted; R3 represents a C1-4 alkyl group which may be substituted or a halogen atom; R4 represents a C1-4 alkyl group which may be substituted; and ring 1 represents a cyclic group which has planarity and may have a substituent group, a salt thereof, an N-oxide thereof or a solvate thereof, or a prodrug thereof, is useful as a medicinal component having CRF antagonistic activity for the prevention and/or treatment of a neuropsychiatric disease, a peripheral organ disease and the like.

A novel pyrrolidine imide catalyzed direct formation of α,β-unsaturated ketones from unmodified ketones and aldehydes

(Chemical Equation Presented) A method for direct, stereoselective preparation of (E)-α,β-unsaturated ketones from ketones and aldehydes, promoted by a novel pyrrolidine imide organocatalyst, has been developed in moderate to high yields. Unlike the Claisen-Schmidt condensation and Lewis acid catalyzed tandem aldol-dehydration processes, this method provides mild reaction conditions to access α,β-unsaturated ketones from simple, unmodified ketones.